Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 689,262
  • Shares Outstanding, K 101,362
  • Annual Sales, $ 131,160 K
  • Annual Income, $ -95,500 K
  • EBIT $ -192 M
  • EBITDA $ -190 M
  • 60-Month Beta -1.27
  • Price/Sales 5.20
  • Price/Cash Flow N/A
  • Price/Book 1.44

Options Overview Details

View History
  • Implied Volatility 182.45% ( +46.62%)
  • Historical Volatility 36.18%
  • IV Percentile 99%
  • IV Rank 88.87%
  • IV High 204.16% on 04/16/25
  • IV Low 9.07% on 08/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 23
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 4,562
  • Open Int (30-Day) 5,043

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.35
  • Number of Estimates 5
  • High Estimate -0.32
  • Low Estimate -0.40
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -600.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.20 +6.94%
on 06/23/25
7.40 -10.41%
on 06/10/25
-0.56 (-7.79%)
since 06/06/25
3-Month
6.08 +9.05%
on 05/16/25
8.09 -18.05%
on 05/02/25
-0.39 (-5.56%)
since 04/07/25
52-Week
6.08 +9.05%
on 05/16/25
16.76 -60.44%
on 11/08/24
-7.08 (-51.64%)
since 07/05/24

Most Recent Stories

More News
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

DAWN : 6.63 (-2.50%)
Day One Reports First Quarter 2025 Financial Results and Corporate Progress

DAWN : 6.63 (-2.50%)
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025

DAWN : 6.63 (-2.50%)
Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

DAWN : 6.63 (-2.50%)
Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025

DAWN : 6.63 (-2.50%)
Day One Reports Preliminary 2024 OJEMDAâ„¢ Net Product Revenue and Highlights 2025 Corporate Priorities

DAWN : 6.63 (-2.50%)
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025

The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were erased in the second half due to disappointing third-quarter results, guidance cuts,...

ALLO : 1.1600 (-2.52%)
IMCR : 32.41 (-1.85%)
DAWN : 6.63 (-2.50%)
Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference

DAWN : 6.63 (-2.50%)
Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development

DAWN : 6.63 (-2.50%)
Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference

DAWN : 6.63 (-2.50%)

Business Summary

Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 7.08
2nd Resistance Point 6.94
1st Resistance Point 6.79
Last Price 6.63
1st Support Level 6.50
2nd Support Level 6.36
3rd Support Level 6.21

See More

52-Week High 16.76
Fibonacci 61.8% 12.68
Fibonacci 50% 11.42
Fibonacci 38.2% 10.16
Last Price 6.63
52-Week Low 6.08

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar